• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $CCJ

    Cameco Corporation

    Subscribe to $CCJ
    $CCJ
    Other Metals and Minerals
    Basic Materials

    Cameco Corporation produces and sells uranium. It operates in two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. This segment also produces fuel bundles or reactor components for CANDU reactors. The company sells its uranium and fuel services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada.

    IPO Year: 1996

    Exchange: NYSE

    Website: cameco.com

    Peers

    $SII
    $DNN

    Recent Analyst Ratings for Cameco Corporation

    DatePrice TargetRatingAnalyst
    5/20/2025$65.00Buy
    Goldman
    4/4/2025Buy
    Desjardins
    4/1/2025$52.00Outperform
    Bernstein
    3/12/2025Buy
    Stifel
    7/31/2024Neutral → Overweight
    Cantor Fitzgerald
    4/1/2024$55.00Buy
    Goldman
    12/19/2023Buy → Neutral
    Cantor Fitzgerald
    11/13/2023Outperform
    RBC Capital Mkts
    11/8/2023Outperform
    BMO Capital Markets
    10/25/2023Hold → Buy
    Cantor Fitzgerald
    See more ratings